Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Clin Breast Cancer. 2021 Jun 7;22(1):e8–e20. doi: 10.1016/j.clbc.2021.05.016

Table 2.

Characteristics in DCIS patients treated with HF-WBI vs. CF-WBI

CF-WBI
(n=126,658)
HF-WBI
(n=26,216)
%HF-WBI AOR (95% CI) a Chi-square*
Age at diagnosis 1430.69
 <40 2,597 190 6.82 1.0 (ref)
 40–44 10,863 1,037 8.71 0.67 (0.52–0.86)
 45–49 17,313 2,082 10.73 0.93 (0.73–1.18
 50–54 19,450 3,379 14.80 1.34 (1.06–1.71)
 55–59 20,450 4,116 16.75 1.62 (1.28–2.05)
 60–64 18,737 4,486 19.32 1.91 (1.50–2.42)
 65–69 16,716 4,510 21.25 2.17 (1.70–2.76)
 70–74 10,859 3,289 23.25 2.92 (2.28–3.73)
 75–79 6,567 1,960 22.99 3.92 (3.05–3.73)
 80+ 3,106 1,167 27.31 6.84 (5.29–8.86)

Race/ethnicity 121.84
 White 97,695 19,836 16.88 1.0 (ref)
 Black 15,813 2,867 15.35 0.79 (0.74–0.85)
 Hispanic 6,225 1,393 18.29 0.91 (0.82–1.00)
 Asian 4,923 1,697 25.63 1.44 (1.32–1.58)
 Other/unknown 2,002 423 17.44 0.95 (0.80–1.12)

Insurance status 25.44
 Not Insured 1,940 371 16.05 1.49 (1.27–1.75)
 Private Insurance 81,418 14,508 15.12 1.0 (ref)
 Medicaid 5,936 1,198 16.79 0.97 (0.88–1.07)
 Medicare 34,392 9,603 21.83 1.02 (0.96–1.09)
 Other Government 1,388 262 15.88 0.94 (0.77–1.14)
 Insurance Status Unknown 1,584 274 14.75 0.99 (0.81–1.22)

Charlson/Deyo comorbidity index 17.41
 0 111,343 22,412 16.76 1.0 (ref)
 1 12,943 3,093 19.29 0.88 (0.83–0.94)
 2 1,911 529 21.68 0.89 (0.77–1.03)
 ≥3 461 182 28.30 0.92 (0.69–1.23)

Tumor size in DCIS 105.61
 ≤ 1.0 cm 48,101 8,392 14.85 1.0 (ref)
 1.1–2.0 cm 23,284 4,218 15.34 0.85 (0.81–0.89)
 2.1–3.0 cm 7,292 1,427 16.37 0.81 (0.76–0.87)
 >3.0 cm 6,515 1,195 15.50 0.72 (0.67–0.78)

Laterality 22.03
 Right 61,535 13,156 17.61 1.0 (ref)
 Left 65,072 13,055 16.71 0.91 (0.87–0.95)

Histology in DCIS 53.71
 Ductal 95,208 20,004 17.36 1.0 (ref)
 Ductal & lobular 3,675 688 15.77 0.90 (0.79–1.03)
 Comedocarcinoma 12,446 2,079 14.31 0.82 (0.77–0.88)
 Cribriform 11,347 2,660 18.99 1.13 (1.06–1.21)
 Papillary 2,952 628 17.54 1.11 (0.98–1.26)
 Paget’s disease 315 77 19.64 0.90 (0.60–1.34)
 Others 715 80 10.06 0.78 (0.55–1.10)

Grade
 1 15,372 2,979 16.23
 2 41,909 9,783 18.93
 3 44,630 9,813 18.02

Estrogen receptor
 Negative 16,418 3,548 17.77
 Positive 95,599 21,842 18.60

Surgical margin 12.46
 Negative 121,253 25,412 17.33 1.0 (ref)
 Positive 4,383 671 13.28 0.80 (0.71–0.91)

Facility locationb 829.62
 New England 10,963 1,740 13.70 1.0 (ref)
 Middle Atlantic 20,629 4,716 18.61 1.05 (0.95–1.16)
 South Atlantic 25,891 5,200 16.73 1.29 (1.18–1.42)
 East North Central 25,097 5,336 17.53 1.35 (1.23–1.48)
 East South Central 6,413 1,159 15.31 1.02 (0.90–1.16)
 West North Central 9,802 1,926 16.42 1.34 (1.20–1.50)
 West South Central 6,930 951 12.07 0.82 (0.72–0.94)
 Mountain 4,102 1,595 28.00 3.72 (3.31–4.19)
 Pacific 14,234 3,403 19.29 1.49 (1.35–1.65)

Facility volume, number of breast cancers per year 460.90
 <120 27,201 3,658 11.85 1.0 (ref)
 120–207 32,772 5,722 14.86 1.40 (1.31–1.49)
 208–342 35,404 7,061 16.63 1.46 (1.37–1.57)
 343+ 30,774 9,120 22.86 2.08 (1.94–2.23)

Facility type 280.67
 Community Cancer Program 72,248 11,971 14.21 1.0 (ref)
 Integrated Network Cancer Program 18,251 4,145 18.51 1.31 (1.24–1.40)
 Academic/Research Program 33,562 9,910 22.80 1.54 (1.46–1.62)

Median household income of residential zip code 61.52
 <$38,000 17,349 3,053 14.96 1.0 (ref)
 $38,000-$47,999 25,658 4,758 15.64 1.07 (1.00–1.16)
 $48,000-$62,999 33,701 6,731 16.65 1.15 (1.07–1.24)
 ≥$63,000 49,360 11,614 19.05 1.29 (1.20–1.39)

Distance to facility
 < 5.0 miles 43,105 8,156 15.91
 5.0–9.9 miles 33,707 6,758 16.70
 10.0–19.9 miles 28,361 6,186 17.91
 20.0–49.9 miles 16,465 3,751 18.55
 ≥ 50.0 miles 4,545 1,321 22.52

Urban/Rural 182.33
 Large metropolis (pop. ≥1 million) 67,695 15,769 18.89 1.0 (ref)
 Metropolis (pop. <1 million) 40,507 6,931 14.61 0.78 (0.75–0.82)
 Urban (pop. ≥20000) 6,515 1,087 14.30 0.87 (0.79–0.97)
 Urban (pop. 2500–19999) 7,084 1,360 16.11 1.17 (1.06–1.28)
 Rural 1,533 380 19.86 1.64 (1.39–1.94)
a

Calculated from multivariable logistic regression, adjusting for year of diagnosis and all other variables with adjusted odds ratios in the table. Variables without adjusted odds ratios were not included in the final logistic regression model.

b

Facility location: New England (CT, MA, ME, NH, RI, VT), Middle Atlantic (NJ, NY, PA), South Atlantic (DC, DE, FL, GA, MD, NC, SC, VA, WV), East North Central (IL, IN, MI, OH, WI), East South Central (AL, KY, MS, TN), West North Central (IA, KS, MN, MO, ND, NE, SD), West South Central (AR, LA, OK, TX), Mountain (AZ, CO, ID, MT, NM, NV, UT, WY), Pacific (AK, CA, HI, OR, WA).

*

All p-values <0.001

Abbreviations: HF-WBI, hypofractionated whole breast irradiation; CF-WBI, conventional fractionated whole breast irradiation; pop., population; AOR, adjusted odds ratio; CI, confidence interval